ArticleCancer reports (Hoboken, N.J.)2025
Prediction of Lung Cancer Metastasis Using Machine Learning Models Based on Clinical Laboratory Data.
Article in Cancer reports (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and validation of a machine-learning-based triage model incorporating systemic inflammatory, nutritional, coagulation, and tumor marker parameters for identifying baseline distant metastasis in lung cancer.Frontiers in oncology · 2026Article
- Prediction of Lung Cancer Metastasis Using Machine Learning Models Based on Clinical Laboratory Data.Cancer reports (Hoboken, N.J.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundLymph node (N) or/and distant metastasis in lung cancer indicates poorer prognosis. While laboratory tests and computed tomography (CT) scans reflect tumor growth and metabolic activity, they usually require combination with other diagnostic methods to effectively assess metastasis, resulting in limited clinical use of these results.
aimsDevelop machine learning models using diverse clinical laboratory data to predict lymph node invasion and skip N metastasis in lung cancer.
methodsThis study performs regression analysis on lung cancer cases initially diagnosed by histopathology, categorized into N and M (skip N metastasis) groups by TNM stage. Laboratory and clinical test results were collected as characteristic parameters. Univariate analysis and lasso regression identified key predictors, and four machine learning algorithms developed the model.
resultsOf the 1629 cases analyzed, 861 were assigned to the N group and 519 to the M group. Univariate analysis revealed significant differences in 40 parameters in Group N and 27 parameters in Group M (p < 0.05). LASSO regression identified 13 characteristic factors for the N group and 12 for the M group. In the N group, the factors included tumor size, prothrombin time (PT), mean platelet volume, fibrinogen, platelet count, procalcitonin, carbohydrate antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA), adenosine deaminase, red blood cell distribution width, thrombin time, smoking history, and alcohol consumption history. In the M group, the factors included cytokeratin 19 fragment, tumor size, CEA, CA 15-3, squamous cell carcinoma antigen (SCCA), alkaline phosphatase, fibrinogen, hemoglobin, calcium, albumin, PT, and absolute monocyte count. The test cohort results indicated that the logistic regression model was optimal for both groups, achieving AUC values of 0.888 and 0.875, respectively.
conclusionThe study demonstrated the potential of using ML algorithms, laboratory data, and clinical features to predict N involvement and skip N metastasis in lung cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.